Genetic Analysis and Targeted Therapy Using Buparlisib and MK2206 in a Patient with Triple Metachronous Cancers of the Kidney, Prostate, and Squamous Cell Carcinoma of the Lung: A Case Report

Genetic Analysis and Targeted Therapy Using Buparlisib and MK2206 in a Patient with Triple Metachronous Cancers of the Kidney, Prostate, and Squamous Cell Carcinoma of the Lung: A Case Report

Tong Zhao,1 Yuqin Tian,2 Xinjia Ding,3 Lin Liu,4 Bowen Tan,5 Bin Yang,5 Jianlin Wu,5 Ting Lei,6 Ruoyu Wang,2 Yan Ding5,7 1Department of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, People’s Republic of China; 2Department of Care Operations, The Affiliated Hospi...

Full description

Bibliographic Details
Main Authors: Zhao T, Tian Y, Ding X, Liu L, Tan B, Yang B, Wu J, Lei T, Wang R, Ding Y
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:OncoTargets and Therapy
Subjects:
multiple primary cancers
next generation sequencing
targeted therapy
buparlisib
bkm120
mk2206
Online Access:https://www.dovepress.com/genetic-analysis-and-targeted-therapy-using-buparlisib-and-mk2206-in-a-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/genetic-analysis-and-targeted-therapy-using-buparlisib-and-mk2206-in-a-peer-reviewed-fulltext-article-OTT

Similar Items